Our People

Dr Richard Kim is a respiratory immunologist (Ph.D. [Immunology and Microbiology] 2015, The University of Newcastle), Head of the ImmunoPharmacology Research Group (IPRG) at the Woolcock Institute of Medical Research and University of Technology Sydney (UTS), and national convenor of the Thoracic Society of Australia and New Zealand (TSANZ) Asthma and Allergy Special Interest Group.

During his postdoctoral training, he was awarded a Lung Foundation Australia & Boehringer Ingelheim postdoctoral research fellowship (2018-2020) and was recruited to University of Technology Sydney as a faculty member in 2019.

Dr Kim is a prominent respiratory researcher who is focused on increasing the understanding of, and developing new treatments for, chronic lung diseases including severe asthma and chronic obstructive pulmonary disease that are major clinical issues in Australia and globally.

To facilitate his research into severe asthma, Dr Kim developed several novel mouse models that replicate different human severe asthma endotypes. Importantly, these models have innovated severe asthma research as valuable pre-clinical discovery and testing platforms. His multidisciplinary research couples these models with cell culture and human sample and bioinformatic analyses to spur advances in the understanding of severe asthma and maximise translation.

View Richard's academic profile